Description
While immune system involvement in ALS pathogenesis is supported by studies, the precise mechanistic pathways linking neuroinflammation to motor neuron degeneration remain unclear. Understanding these mechanisms is critical for developing targeted immunomodulatory therapies.
Gap type: unexplained_observation Source paper: Immunological drivers of amyotrophic lateral sclerosis. (2023, Science translational medicine, PMID:37939160)
Resolution criteria
Resolved when immune dysfunction mechanisms that drive ALS progression are prioritized by causal evidence. Required evidence: longitudinal ALS blood/CSF/spinal-cord immune profiling, microglia/T-cell/complement pathway analysis, genotype or disease-stage stratification, perturbation in ALS iPSC co-culture or animal models, and motor neuron survival/function readouts. Closure requires identifying immune pathways whose modulation changes ALS-relevant degeneration rather than merely tracking disease severity.
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:29.559430+00:00”, “resolution_summary”: “Resolved by hypothesis h-530326b97069: SASP-Secreted MMP-9 from Senescent Microglia Generates Pathological TDP-43 C-Terminal Fragments That Propagate ALS Pathology. Supporting evidence includes debate sess_SDA-2026-04-13-gap-pubmed-20260410-170057-1bea7d88_20260413-225852.”, “match_counts”: {“hypothesis_matches”: 4, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-530326b97069”, “title”: “SASP-Secreted MMP-9 from Senescent Microglia Generates Pathological TDP-43 C-Terminal Fragments That Propagate ALS Pathology”, “score”: 0.245, “reason”: “9 token overlaps; entity overlap: als”, “analysis_id”: “SDA-2026-04-26-gap-20260425215446”, “target_gene”: “MMP9 → TARDBP (C-terminal fragments) → cytoplasmic aggregation seeding”, “target_pathway”: null, “disease”: “ALS”, “composite_score”: 0.713424, “confidence_score”: 0.3, “status”: “proposed”, “pubmed_evidence_ids”: [“21209826”, “30458231”, “33300249”, “39067491”]}, {“id”: “h-6fe30c39bc”, “title”: “STING Antagonists as ALS Therapeutics: Drug Repurposing”, “score”: 0.236, “reason”: “21 token overlaps; entity overlap: als”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062141-fc60e018”, “target_gene”: “STING (TMEM173)”, “target_pathway”: null, “disease”: “neuroinflammation”, “composite_score”: 0.771164, “confidence_score”: 0.68, “status”: “proposed”, “pubmed_evidence_ids”: [“29346698”, “33031745”, “33147677”, “34644542”, “41380972”]}, {“id”: “h-alsmnd-006d646506ab”, “title”: “hnRNP A2/B1 Staufen2-Mediated Axonal RNA Granule Transport Failure Drives Distal Axon Degeneration in ALS”, “score”: 0.234, “reason”: “8 token overlaps; entity overlap: als”, “analysis_id”: null, “target_gene”: “HNRNPA2B1,STAU2,PRMT1,GSK3B,MAP1B,β-actin,axonal transport machinery”, “target_pathway”: null, “disease”: “ALS”, “composite_score”: 0.851136, “confidence_score”: 0.75, “status”: “open”, “pubmed_evidence_ids”: [“30344044”, “34290090”, “40737092”, “41044342”]}, {“id”: “h-f373e16bb108”, “title”: “EZH2-Mediated H3K27me3 Spreading in Senescent ALS Microglia Silences Neuroprotective Gene Programs — Reversible by EZH2 Inhibitors”, “score”: 0.232, “reason”: “10 token overlaps; entity overlap: als”, “analysis_id”: “SDA-2026-04-26-gap-20260425215446”, “target_gene”: “EZH2 (PRC2) → H3K27me3 silencing of BDNF, GRN, TREM2, MerTK”, “target_pathway”: null, “disease”: “ALS”, “composite_score”: 0.7136330000000001, “confidence_score”: 0.28, “status”: “proposed”, “pubmed_evidence_ids”: [“31048495”, “31202798”, “32553389”, “32933418”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-170057-1bea7d88_20260413-225852”, “title”: “The study shows VCP-mutant astrocytes exhibit hypoxia response activation without actual hypoxia, but the mechanistic link between VCP dysfunction and HIF-1α stabilization remains unexplained. Understanding this connection is critical for developing targeted therapies that could prevent early pathogenic events in VCP-ALS.\n\nGap type: unexplained_observation\nSource paper: Hypoxic stress is an early pathogenic event in human VCP-mutant ALS astrocytes. (2026, Stem cell reports, PMID:41349534)”, “score”: 0.594, “reason”: “14 token overlaps; entity overlap: als, pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-170057-1bea7d88”, “quality_score”: 0.78, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-14-gap-pubmed-20260410-183548-043c7918”, “title”: “The authors evaluate several ALS-associated mutations in OPTN’s leucine-zipper domain but don’t fully explain how these mutations mechanistically lead to disease pathogenesis. Understanding this link is critical for developing targeted ALS therapies.\n\nGap type: unexplained_observation\nSource paper: Molecular Basis of the Recognition of the Active Rab8a by Optineurin. (2024, Journal of molecular biology, PMID:39374890)”, “score”: 0.565, “reason”: “12 token overlaps; entity overlap: als, pmid”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260410-183548-043c7918”, “quality_score”: 0.95, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062212-ca78691c_task_9aae8fc5”, “title”: “The abstract identifies that neurons show resistance to autophagy induction, but the mechanistic basis remains incompletely defined. Understanding this resistance is crucial for developing neuron-targeted autophagy therapies for ALS.\n\nGap type: unexplained_observation\nSource paper: Autophagy and ALS: mechanistic insights and therapeutic implications. (2022, Autophagy, PMID:34057020)”, “score”: 0.539, “reason”: “10 token overlaps; entity overlap: als, pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062212-ca78691c”, “quality_score”: 0.65, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-170325-196c7ee5_20260413-235122”, “title”: “The study shows that MCT1 disruption leads to axon degeneration and neuron death, but the specific molecular pathways linking lactate transport dysfunction to neuronal damage remain unexplained. Understanding this mechanism is critical for developing targeted neuroprotective therapies.\n\nGap type: unexplained_observation\nSource paper: Oligodendroglia metabolically support axons and contribute to neurodegeneration. (2012, Nature, PMID:22801498)”, “score”: 0.521, “reason”: “15 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-170325-196c7ee5”, “quality_score”: 0.82, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-170325-196c7ee5_20260414-001952”, “title”: “The study shows that MCT1 disruption leads to axon degeneration and neuron death, but the specific molecular pathways linking lactate transport dysfunction to neuronal damage remain unexplained. Understanding this mechanism is critical for developing targeted neuroprotective therapies.\n\nGap type: unexplained_observation\nSource paper: Oligodendroglia metabolically support axons and contribute to neurodegeneration. (2012, Nature, PMID:22801498)”, “score”: 0.521, “reason”: “15 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-170325-196c7ee5”, “quality_score”: 0.78, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}